Large-capacity separation of malignant cells and lymphocytes from the Furth mast cell tumor in a reorienting zonal rotor. 1980

C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow

The Furth murine mastocytoma was adapted to the ascitic form and separated into fractions enriched with respect to lymphocytes and malignant cells by velocity sedimentation in the SZ-14 reorienting zonal rotor or in the isokinetic gradient. Lymphocytes were more highly purified (p less than 0.01) in the isokinetic gradient than in the zonal rotor, i.e., lymphocytes comprised 99.1% of the nucleated cells in the purest fraction from the isokinetic gradient and 80.1% of the nucleated cells in the purest fraction from the zonal rotor. Neoplastic mast cells were similarly purified by the two methods; they comprised 67.7 and 78.5% of the nucleated cells in the purest fractions from the isokinetic gradient and zonal rotor, respectively. Up to 160 million tumor cells can be purified in a single step with the reorienting zonal rotor, whereas 30 to 40 million cells per gradient approach the limit of the isokinetic gradient. After centrifugation in the zonal rotor, recovery was 85.6 +/- 12% (S.D.) of the cells layered over the gradient; and the separated tumor cells retained their ability to form tumors when transplanted into mice. The separation of large numbers of lymphocytes and malignant cells from the same tumor in the SZ-14 rotor should aid in the biochemical and immunological characterization of cancer.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002499 Centrifugation, Density Gradient Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Centrifugations, Density Gradient,Density Gradient Centrifugation,Density Gradient Centrifugations,Gradient Centrifugation, Density,Gradient Centrifugations, Density
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D012515 Mast-Cell Sarcoma A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow. Mastocytoma, Malignant,Sarcoma, Mast-Cell,Malignant Mastocytoma,Malignant Mastocytomas,Mast Cell Sarcoma,Mast-Cell Sarcomas,Mastocytomas, Malignant,Sarcoma, Mast Cell,Sarcomas, Mast-Cell
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
November 1980, Clinical and experimental immunology,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
October 1969, Analytical biochemistry,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
February 1977, Cancer research,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
April 1975, Analytical biochemistry,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
March 1972, Analytical biochemistry,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
January 1971, Analytical biochemistry,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
May 1981, Analytical biochemistry,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
July 1973, Analytical biochemistry,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
August 1979, Neurochemical research,
C L Green, and T P Pretlow, and K A Tucker, and E L Bradley, and W J Cook, and A M Pitts, and T G Pretlow
June 1970, Journal of the National Cancer Institute,
Copied contents to your clipboard!